39LOW

EZZ

EZZ LIFE FPO [EZZ]
EZZ Life Science Holdings Limited engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and South-East Asia. The company operates through two segments, Brought in Lines and Company Owned Products. It is involved in the wholesale distribution of the EAORON branded skin care products to retailers; and direct-to-consumer distribution through e-commerce store. The company provides health and wellness products under the EZZ brand. It also offers its products online. The company was incorporated in 2015 and is based in Lidcombe, Australia.
Healthcare · ASX Small Cap
$0.8900 +0.0%

Updated 26 Mar 2026 · Scores refresh every scan

Score Breakdown

Technical64
Catalyst50
Sentiment50
Fundamental91
Momentum36
Risk Gate50
Get alerts when EZZ's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Track EZZ — Free

Active Signals

Bullish Signals

  • RSI is looking oversold — historically a spot where stocks tend to bounce
  • MACD momentum is picking up steam
  • Stochastic is deep in oversold territory — bounce conditions forming
  • Lagging the Small Ords index — relative strength of 0.65, underperforming its peers
  • Volatility is contracting — like a spring being compressed, breakouts often follow
  • Strong cash runway (22 quarters)
  • 4C filed 2026-01-30
  • Low P/S ratio (0.7x)
  • Revenue in sharp decline (-18%)
  • EPS estimates revised upward (+10pts)
  • Near 52-week low (1% of range)
  • Small-cap ($20-100M)
  • CANSLIM A: Strong annual earnings CAGR (72%)
  • CANSLIM S: Tight float (28%)
  • Sentiment is mixed — no strong consensus either way
  • Beneish M-Score -1.76 > -1.78: likely earnings manipulation
  • RBA hiking (-3pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Revenue declining at -18% — the top line is shrinking
  • The bigger volume days are the down days — volume-weighted momentum is negative (-0.30%/day)
  • Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about EZZ
"What's driving EZZ's score?" "How does EZZ compare to peers?" "Key risks for EZZ?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Half Yearly Report and Accounts
NONE EZZ Appoints Aumake in $10m Exclusive Distributor Agreement
NONE $10m Exclusive Distribution Agreement with EZZ Life Sciences
LOW Quarterly Activities/Appendix 4C Cashflow Report

Recent ASX Announcements

2026-02-27 Half Yearly Report and Accounts PRICE SENSITIVE
2026-02-16 EZZ Appoints Aumake in $10m Exclusive Distributor Agreement PRICE SENSITIVE
2026-02-16 $10m Exclusive Distribution Agreement with EZZ Life Sciences PRICE SENSITIVE
2026-01-30 Quarterly Activities/Appendix 4C Cashflow Report PRICE SENSITIVE

Key Metrics

$41.6M
Market Cap
37K
Avg Volume
0.7x
Vol Ratio
$0.86 — $3.38
52-Week Range
N/A
Short Interest
20 qtrs
Cash Runway
11.2%
ROE
4.7%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSneutralEPS Growth: 0%
AAnnual EarningspassCAGR: 72%
NNew Highs / Catalystsneutral
SSupply & DemandpassFloat: 28%
LLeader vs LaggardlaggardRS: -8
IInstitutional SponsorshipweakInst: 1%
MMarket DirectionneutralNeutral

Sector: Healthcare

Ranked #93 of 117 · Sector avg: 46

View all Healthcare signals →
Related Tickers
ATX 59PNV 56IMM 55EYE 55AHC 55
Compare:EZZ vs ATXEZZ vs PNVEZZ vs IMM
Scout Pro — Deeper Analysis for EZZ
Try Pro free for 30 days
Share this analysis

Track EZZ and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required